Lakewood-Amedex Biotherapeutics (LABT) vs Scinai Immunotherapeutics (SCNI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lakewood-Amedex Biotherapeutics is the larger company by market cap ($1.9 million vs $1.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LABT | SCNI |
|---|---|---|
| Share price | $0.792 | $1.21 |
| Market cap | $1.88M | $1.64M |
| 1-day change | -6.80% | +7.08% |
| P/E ratio (TTM) | — | 0.04 |
| EPS (TTM) | $-8.83 | $28.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $98.20 | $15.65 |
| 52-week low | $0.76 | $1.06 |
| Distance from 52-week high | -99.19% | -92.27% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1415.15% | — |
| Average volume | 2.50M | 1.10M |
| Shares outstanding | 2.37M | 1.35M |
| Employees | 5 | 45 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Healthcare · Biotechnology · 5 employees
About Scinai Immunotherapeutics
SCNI stock →Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis.
Healthcare · Biotechnology · 45 employees
LABT vs SCNI FAQ
Which is bigger, Lakewood-Amedex Biotherapeutics or Scinai Immunotherapeutics?
Lakewood-Amedex Biotherapeutics (LABT) is larger, with a market capitalization of $1.88M compared with $1.64M for Scinai Immunotherapeutics (SCNI).
Are Lakewood-Amedex Biotherapeutics and Scinai Immunotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.